The PD-L1 CTC Panel

The PD-L1 CTC Panel enables the determination of the PD-L1 biomarker in CTCs by immunofluorescence analysis. It is known that patients with PD-L1 positivity have a better response to immune checkpoint suppressive drugs. The status of the PD-L1 marker plays an important role in determining the outcome of the disease and success of the treatment, especially in lung cancer.

The kit contains all necessary solutions for PD-L1 staining. The PD-L1 CTC Panel is used with CTC identification panel.

Breast cancer cell stained with PD-L1 CTC Panel

For more information contact us at